Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address: Raatuse 21
City: Tartu
State: tartu county
Zip: 50603
Country: EE
Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detection measures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Seed | $2.4M |
Enterprise Estonia European Institute of Innovation and Technology |
11/2021 | Equity | $577.2k | 8/2022 | Seed Round | 4 | $1.6M |
Aare Kurist Andreas Henn Otsmaa Peep Vain Timo Rein Aare Kurist Andreas Henn Otsmaa Peep Vain Timo Rein |
8/2022 | Grant | $0 |
EIT - European Institute of Innovation and Technology Enterprise Estonia EIT - European Institute of Innovation and Technology Enterprise Estonia |
2/2018 | Angel Round | $312.8k | 11/2021 | Pre Seed Round | $574.3k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|